EEA

Republic of Suriname Announces Successful Settlement of Invitation

Retrieved on: 
Thursday, December 7, 2023
MAKE, Sale, Invitation, Gross metropolitan product, European Economic Area, Table (information), AB8, Information, Block, Lazard, New security concept, White & Case, ANY, CUSIP, Eligibility, EEA, Person, SEC Rule 144A, Legal opinion, Effective date, AND, Security (finance), Financial adviser, Customer service, Republic, Regulation

The Invitation expired at 5:00 pm, New York City time, on November 3, 2023 (the "Expiration").

Key Points: 
  • The Invitation expired at 5:00 pm, New York City time, on November 3, 2023 (the "Expiration").
  • The Republic is pleased to announce that following the satisfaction of the Legal Opinion Condition (as defined in the Invitation) and the execution of the New Indentures and supplemental indentures between the Republic and the relevant trustee, settlement of the transaction occurred on December 6, 2023.
  • The New Indentures and the terms of the New Securities have been given effect as of the Effective Date.
  • Holders of each series of Eligible Bonds were entitled to receive the specific consideration described in the Invitation, subject to rounding as described in the Invitation.

EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million

Retrieved on: 
Thursday, December 14, 2023
XETRA, Financial services, Ruxolitinib, Relevance (Person of Interest), Frankfurt Stock Exchange, Regulation, Person, FSE, Wells Fargo, AMERICA, Qualification, Gross metropolitan product, Prospectus, Investment, EUR, Failure, MorphoSys, UBS, SEC Rule 144A, European Parliament, European Economic Area, Finance, BET, Council, Truist, Jefferies, Acquisition, EEA, Security (finance), Pharmaceutical industry, Order

The 3,423,194 new ordinary bearer shares with no-par value (Stückaktien) (“New Shares”) have been placed with institutional investors at a placement price of EUR 30.00 per new share by way of an accelerated bookbuilding, resulting in gross proceeds of approximately EUR 102.7 million.

Key Points: 
  • The 3,423,194 new ordinary bearer shares with no-par value (Stückaktien) (“New Shares”) have been placed with institutional investors at a placement price of EUR 30.00 per new share by way of an accelerated bookbuilding, resulting in gross proceeds of approximately EUR 102.7 million.
  • “MorphoSys’ oncology pipeline offers promising value-creating opportunities, with pelabresib, our investigational BET inhibitor, at the forefront,” said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys.
  • “With pelabresib, we have the potential to shift the treatment paradigm in myelofibrosis, a field in dire need of innovation.
  • The placement price represents a discount of 2.8% compared to the 5-day volume-weighted average price (XETRA) of the Company’s shares.

EQS-News: ams OSRAM announces the offering of EUR 800 million equivalent senior notes as part of its recently presented financing plan

Retrieved on: 
Thursday, December 14, 2023
AMERICA, OSRAM, AMS, Prospectus, Financial services, SALES, EUR, Nature, Person, Finance, SEC Rule 144A, Debt-to-GDP ratio, KID, Sale, Ams-OSRAM, EEA, Investment, Security (finance), Note

Premstaetten, Austria, and Munich, Germany (13 November 2023) – ams OSRAM (SIX: AMS) announced today the launch of an offering of EUR 800 million equivalent aggregate principal amount of senior unsecured notes, comprising euro denominated senior unsecured notes due March 2029 and dollar denominated senior unsecured notes due March 2029 (together, the "Notes") as part of its recently presented financing plan.

Key Points: 
  • Premstaetten, Austria, and Munich, Germany (13 November 2023) – ams OSRAM (SIX: AMS) announced today the launch of an offering of EUR 800 million equivalent aggregate principal amount of senior unsecured notes, comprising euro denominated senior unsecured notes due March 2029 and dollar denominated senior unsecured notes due March 2029 (together, the "Notes") as part of its recently presented financing plan.
  • There will be no public offering of Notes in the United States of America.
  • Manufacturer target market (MIFID II product governance) for the Notes is eligible counterparties and professional clients only (all distribution channels).
  • This announcement may contain statements about ams OSRAM (the “Company”, and together with its subsidiaries the “Group”) that are or may be “forward-looking statements”.

Aeterna Zentaris Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
MFDS, European Economic Area, Result, AIM, Conversation, Research, Bank statement, Financial condition report, ALS, Neuromyelitis optica spectrum disorder, Marketing, Analysis, EEA, NMOSD, Patient, TSX, General Administration of Press and Publication, Cryptocurrency, Clothing, Rare-earth element, Aeterna

TORONTO, ONTARIO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the quarter ended September 30, 2023.

Key Points: 
  • - Ended the quarter with $38.8 million in cash, expected to fund operations and advancement of priority pipeline programs into 2025
    TORONTO, ONTARIO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the quarter ended September 30, 2023.
  • Dollars
    The Company had $38.8 million in cash and cash equivalents at September 30, 2023.
  • Our total revenue for the nine-month period ended September 30, 2023, was $4.4 million as compared to $3.2 million for the same period in 2022, representing an increase of $1.2 million.
  • For reference, the Company’s Management's Discussion and Analysis of Financial Condition and Results of Operations for the third quarter 2023, as well as the Company's unaudited consolidated interim financial statements as of September 30, 2023, will be available on the Company's website ( www.zentaris.com ) in the Investors section or at the Company's profile at www.sedarplus.com and www.sec.gov .

ESMA publishes analysis on the evolution of EEA share market structure since the application of MiFID II

Retrieved on: 
Thursday, November 9, 2023
Markets in Financial Instruments Directive 2014, EEA, ESMA, Review, Regulation, Medical device, Transport, EU

ESMA publishes analysis on the evolution of EEA share market structure since the application of MiFID II

Key Points: 
  • ESMA publishes analysis on the evolution of EEA share market structure since the application of MiFID II
    ESMA publishes today an article on the evolution of the European share market structure from 2019 to 2022, following the implementation of the markets in financial instruments directive (MiFID II).
  • Specific focus is given to the impact of the UK’s withdrawal from the EU, given its pivotal role in equity markets.
  • The European market structure has changed in an important manner during the observed period.
  • Background
    This topic is of relevance to ESMA in terms of both its financial stability and orderly markets mandate, since competition among trading venues can lead to more innovative services and lower fees, but a fragmented trading landscape can also impact market liquidity.

Rising Demand for Multi-Core Microcontrollers (MCUs) and Automotive Ethernet Chips in Evolving E/E Architectures

Retrieved on: 
Thursday, November 9, 2023
Aion, GAC, PHY, SOA, Marvell, Infineon Technologies, University of London, NXP, Originality, Family, SDV, Architecture, MCU, Original equipment manufacturer, MAC, Gigabit Ethernet, Huawei, Software, Socs, Broadcom Inc., Qualcomm, Demand, ECU, EEA, USD, Visteon, Renesas Electronics, PCI Express, Communication, Instrumentation, Video game, Computer data storage, ADAS

In the rapidly evolving landscape of automotive Electronic/Electrical Architecture (EEA), significant transformations are on the horizon.

Key Points: 
  • In the rapidly evolving landscape of automotive Electronic/Electrical Architecture (EEA), significant transformations are on the horizon.
  • The automotive industry is witnessing a paradigm shift towards central computing architectures with functional logics centralized in one central controller.
  • Under the zonal architecture, Multi-Core Microcontrollers (MCUs) with high performance are in demand to meet the growing computing needs.
  • The Demand for Automotive Ethernet PHY and Switch Chips:
    The adoption of zonal architecture fuels a surge in demand for automotive Ethernet PHY and switch chips, resulting in price fluctuations.

HSBC Continental Europe: Pre Stabilisation Notice

Retrieved on: 
Wednesday, November 8, 2023
London, Sale, United Kingdom, Financial Conduct Authority, Financial services, Issuer, RNS, London Stock Exchange, Person, State, Exercise, Prospectus, Financial Services and Markets Act 2000, EEA, Finance, Investment, Greenshoe, Security (finance), EU

However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.

Key Points: 
  • However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time.
  • Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.
  • This announcement is not an offer of securities for sale into the United States.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Sandoz successfully issues EUR 2.0 billion inaugural Eurobonds

Retrieved on: 
Wednesday, November 8, 2023
FOR, J. P. Morgan, EBITDA, Person, Mizuho, NOT, OR, BNP Paribas, KID, Linklaters, BBB, Media release, S&P, AND, CHF, Security (finance), Bank, Novartis, BAA2, EUR, EEA

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

Key Points: 
  • NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN
    Inaugural Eurobonds priced earlier today; three tranches of EUR 700 million, EUR 700 million and EUR 600 million
    Basel, November 8, 2023 – Sandoz, the global leader in generic and biosimilar medicines, today announced the issuance of three highly successful inaugural Eurobonds, with total gross proceeds of EUR 2.0 billion.
  • Following a debut transaction in CHF last month, this issuance marks the entry of Sandoz into the EUR debt capital market.
  • Colin Bond, Sandoz CFO said: "These inaugural bonds represent a further milestone for Sandoz, establishing us firmly as a new issuer in the EUR bond market and creating a diversified and well-balanced financing profile from a currency and maturity perspective."
  • The proceeds, together with those from last month’s CHF issuance, will be used for the repayment of the EUR 2.4 billion bridge loan and for general corporate purposes.

UVDI Announces CE Mark for V-MAX™ Technology

Retrieved on: 
Wednesday, November 8, 2023
Architecture, Other Construction & Property, Technology, Other Education, Commercial Building & Real Estate, HVAC, Environment, Construction & Property, Education, Building Systems, Other Technology, Manufacturing, OEM, European Economic Area, Distributor, Temperature, Health, Innovation, SARS-CoV-2, United Nations, Innovative Satellite Technology Demonstration Program, CE, Atmosphere, Maintenance, Distribution, Multimedia, Hospital, School, European Free Trade Association, EEA, Air handler, Los Angeles International Airport, European, Test management, Heating, ventilation, and air conditioning

UltraViolet Devices, Inc. (UVDI), a leading manufacturer of advanced UV-C Indoor Air Quality and surface disinfection technology, announced today that its V-MAX™ air disinfection and coil cleaning products now carry the CE mark.

Key Points: 
  • UltraViolet Devices, Inc. (UVDI), a leading manufacturer of advanced UV-C Indoor Air Quality and surface disinfection technology, announced today that its V-MAX™ air disinfection and coil cleaning products now carry the CE mark.
  • Today, UVDI V-MAX technology is trusted for clean, disinfected and more comfortable air supply, as well as improved energy-efficiency in over 1,500 facilities worldwide, including hospitals, schools, airports, stadiums, office buildings and industrial sites.
  • View the full release here: https://www.businesswire.com/news/home/20231107288786/en/
    V-MAX UV-C Air Disinfection and Coil Cleaning technology helps create cleaner, more comfortable air supply in over 1,500 commercial buildings worldwide.
  • To inquire about partnering with UVDI, please contact David Heidel, Global Sales Director, Airside at [email protected] or visit www.uvdi.com .

Striga Powers Bitwala's Comeback to European Crypto

Retrieved on: 
Wednesday, November 8, 2023
Bitcoin, Ethereum, Euro, European Economic Area, Lightning, Heart, Visa, Single Euro Payments Area, Lightning Network, API, Partnership, BTC, SEPA, Cryptocurrency, Striga, EEA, EU, Nuri (company)

However, with the support of Striga, compliant crypto & banking APIs, it has relaunched under its original name, Bitwala.

Key Points: 
  • However, with the support of Striga, compliant crypto & banking APIs, it has relaunched under its original name, Bitwala.
  • Bitwala's relaunch focused on returning to its core offering, which centers around buying and selling crypto.
  • "Buying and selling crypto has always been at the heart of Bitwala's business," notes Jan Goslicki, Bitwala's Chief Experience Officer.
  • Future plans for the platform include integrating the Lightning Network and introducing a crypto-backed Visa debit card, all of which are being developed in collaboration with Striga.